Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Optimizing Clinical Outcomes in Acute Decompensated Heart Failure
Author(s): Sabu Thomas , Andrew J Boyle , Gary S Francis Added: 3 years ago
Acute decompensated heart failure (ADHF) is a syndrome defined by worsening fatigue, dyspnea, or edema that results from deteriorating heart function and usually leads to hospital admission or unscheduled medical intervention.1 Among patients over 65 years of age it remains the leading cause of hospital admission (>1 million admissions per year in the US alone), has an exceptionally high rate… View more

Heart Failure
Author(s): Mihai Gheorghiade Added: 3 years ago
An episode of acute heart failure syndromes (AHFS) can be defined as a rapid or gradual onset of signs and symptoms of heart failure that result in hospital admission. Over 70% of AHFS events are the result of worsening chronic heart failure.1 Other causes of AHFS include new-onset heart failure due to an acute coronary event, such as a myocardial infarction (MI), and end-stage or refractory… View more

Heart Failure
HFSA 22: HearO™ Community Study: Remote Speech Analysis of Hospitalized Pts With Acute Decompensated HF New Technology
Author(s): William T Abraham Added: 1 year ago
HFSA 2022 — Dr William T Abraham (The Ohio State University, US) talks about a study assessing a remote speech analysis application, Cordio app (Cordio Medical) that evaluated hospitalized patients with acute decompensated heart failure (NCT03266029). Questions What is the background of this study? What is the Cordio app and what is the premise behind the HearO System? What is the study design… View more

Heart Failure

Digital Health
John J Atherton
Job title: Director of Cardiology
Dr John Atherton is Director of Cardiology, Royal Brisbane and Women’s Hospital, Associate Professor, University of Queensland, and Adjunct Professor, Queensland University of Technology. Dr Atherton was on the board of the Cardiac Society of Australia and New Zealand (CSANZ, 2009–2015) and chairs the CSANZ Professional Ethics Standards Committee. He previously chaired the Asia-Pacific Acute… View more
Focused Ultrasound in the Emergency Department for the Diagnosis of Acute Heart Failure by Dr. Frances Russell
Author(s): Frances M Russell Start date: Jan 12, 2016

Heart Failure
Optimizing GDMT for HFrEF During Hospitalization
Author(s): Neal M Dixit , Shivani Shah , Boback Ziaeian , et al Added: 2 years ago

Heart Failure
The Contemporary Cardiogenic Shock ‘Playbook’
Author(s): Alexander G Truesdell Added: 2 years ago

Standards & Guidelines

Heart Failure
Author(s): Maria Rosa Costanzo Added: 3 years ago
In the US, 90% of the one million annual hospitalizations for heart failure (HF) are due to volume overload.1,2 Hypervolemia contributes to HF progression and mortality. Guidelines recommend that therapy for HF patients be aimed at achieving euvolemia. Intravenous loop diuretics induce rapid diuresis that reduces lung congestion and dyspnea. However, the effectiveness of loop diuretics declines… View more

Heart Failure
ACC 23: BMAD Trial: μCor in Ambulatory Decompensated Heart Failure
Author(s): John Boehmer Added: 1 year ago
ACC.23/WCC –We are joined on-site by Dr John Boehmer (Penn State Health, US) to discuss the findings of the BMAD-TX Trial, originally revealed at ACC 2023 (Zoll Medical Corporation). In this study, investigators aimed to assess the impact of a novel wearable sensor, the Microcor, (μCor™) in the management of heart failure. 266 patients with ambulatory decompensated heart failure were enrolled in… View more

Imaging & Diagnostics

Heart Failure
AHA 2021 Late-breaker Discussion: The EMPULSE Trial
Author(s): Harriette Van Spall , Adriaan A Voors Added: 2 years ago
In this in-depth conversational interview, Late-breaker host Dr Harriette Van Spall (McMaster University, CA) meets PI, Prof Adriaan Voors (University Medical Center Groningen, NL) to discuss the EMPULSE trial. The aim of the trial was to evaluate empagliflozin compared with placebo among patients with acute decompensated heart failure. Presented first at AHA 2021, the trial showed that that… View more

Heart Failure